Menu
Dr Gregory Nalesnik has 5 years of physician experience (3 in paediatrics residency, 2 in pediatric heme/onc fellowship). He actively researches high-risk leukaemia drug discovery and metabolic pathways of chemotherapy resistance.
Dr Gregory Nalesnik is a member of the M3 Panel since 2023
“Physicians have unique and valuable insights into the healthcare marketplace that they can utilize in market research.”
Access to paid market research studies within your medical specialty
Being an M3-Member creates opportunity to shape future healthcare developments by sharing your medical expertise and opinions
Studies are digital, easy to access, and you only participate in the ones you are interested in and have time for
Read Dr Gregory Nalesnik’s interview "Why Become an Oncologist?"
